AI-generated summary
The authors report a single-center, self-controlled prospective study of 12 patients with diabetic macular edema treated with photobiomodulation during nighttime darkness, with follow-up over 12 months. They found improved best-corrected visual acuity and reduced maximal and average retinal thickness at later follow-up, with no fundus complications observed. The authors describe PBM as safe and effective but call for further investigation, and the small uncontrolled design limits these conclusions.
- Participants
- 12
- Who or what was studied
- 12 patients (5 males, 7 females; 20 eyes) with diabetic retinopathy and diabetic macular edema, mean age 56 years (range 26-68)
- Limits stated in the abstract
- The study is a small, single-center, self-controlled prospective study without a separate control group, so the findings are preliminary.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Retina. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.